Case Studies Details


View All

Awareness Trial Usage (ATU) Study for Renal Cell Carcinoma


This BA Health’s case study tracked awareness, perception & behavior of oncologists in the treatment of Renal Cell Carcinoma (RCC). The client wanted to have a clear picture of the prevailing and future therapy usage in the neoadjuvant & metastatic setting, evaluate the product attributes that are most likely to be prescribed, and gauge the awareness of new agents in development. This quantitative study targeted oncologists and hematologists throughout the USA to assess the mentioned medical professionals’ attitudes and perceptions on targeted therapies and angiogenesis inhibitors in RCC treatment. This case study details the tools used as a part of the statistical technique to derive the outcome of the study which further enabled the brand teams to create targeted messages

Study Type Quantitative Research

Geography USA

Sample Size n=100

Target Group Medical oncologist Hematologist